Chemotherapy-induced Nausea and Vomiting Control

Chemotherapy-induced Nausea and Vomiting Control

Contact

 If you are interested in participating in the study or want to learn more, please contact: Contact us
This study is now recruiting. Learn more about enrolling here.

Description

For patients (and parents of patients) that have been diagnosed with, pediatricacute lymphoblastic leukemia (ALL), nausea and vomiting are among the most bothersomesymptoms during chemotherapy treatment.The overall goal of this study is to find the best strategies used by parentsand patients for managing these symptoms when receiving maintenance therapy.

Eligibility and criteria
IRB Number:
21-018666
Eligible age range:
1 months - 18 years
Clinical trial phase:
N/A
Official title:
Chemotherapy-induced Nausea and Vomiting Control: Understanding Preferences of Pediatric Patients and their Parents

What to expect

This study will enroll parents/guardians of patients that have been diagnosedwith pediatric acute lymphoblastic leukemia (ALL) that are 18 years old and younger and patients that have been diagnosed with ALL that are 13-18 years old. Participants will be invited to share theirexperience with chemotherapy-induced nausea and vomiting (CINV). Interviewswill be conducted in person or virtually using a moderator guide that centersaround discussion surrounding CINV management. 
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.